Innovative Cellular Therapeutics
高管
查看带有其 5 名主要高管的组织结构图
Innovative Cellular Therapeutics 搜索最多的简介
- Lei Xiao, Chairman, Chief Executive Officer and Chief Scientific O...
- Lee Tian, Senior Vice President and Head of Intellectual Property
- Xiaobin Lu, Chief Technology Officer
创建提醒
跟踪 Innovative Cellular Therapeutics 的高管变动
生物技术
Innovative Cellular Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Innovative Cellular Therapeutics 的最新新闻稿
- European Society for Medical Oncology (ESMO) Congress 2023
- Presented Data at the American Society of Gene and Cell Therapy
- Presented Updated Data at the American Association for Cancer
- News - Innovative Cellular Therapeutics
- Innovative Cellular Therapeutics (ICT) Announces First Patient Enrolled
- ICT Announces Presentation at 2022 ASCO Annual Meeting
- ICT to Present at the ASGCT 25th Annual Meeting
- Robert Dallimore as SVP of Quality & Compliance
- Robert Dallimore as SVP of Quality & Compliance
- Robert Dallimore as SVP of Quality & Compliance
- View more press releases Close
通过电子邮件
